Davide Seruggia
Davide Seruggia
Boston Children's Hospital and Harvard
Verified email at enders.tch.harvard.edu - Homepage
Cited by
Cited by
Mouse genome editing using the CRISPR/Cas system
DW Harms, RM Quadros, D Seruggia, M Ohtsuka, G Takahashi, ...
Current protocols in human genetics 83 (1), 15.7. 1-15.7. 27, 2014
The new CRISPR-Cas system: RNA-guided genome engineering to efficiently produce any desired genetic alteration in animals
D Seruggia, L Montoliu
Transgenic Research, 2014
Targeting the CBM complex causes T reg cells to prime tumours for immune checkpoint therapy
M Di Pilato, EY Kim, BL Cadilha, JN Prüßmann, MN Nasrallah, ...
Nature 570 (7759), 112-116, 2019
MIR retrotransposon sequences provide insulators to the human genome
J Wang, C Vicente-García, D Seruggia, E Moltó, A Fernandez-Mińán, ...
Proceedings of the National Academy of Sciences 112 (32), E4428-E4437, 2015
Functional validation of mouse tyrosinase non-coding regulatory DNA elements by CRISPR-Cas9-mediated mutagenesis
D Seruggia, A Fernández, M Cantero, P Pelczar, L Montoliu
Nucleic Acids Research, gkv375, 2015
Atomic force microscopy study of DNA conformation in the presence of drugs
V Cassina, D Seruggia, GL Beretta, D Salerno, D Brogioli, S Manzini, ...
European Biophysics Journal 40 (1), 59-68, 2011
Binary recombinase systems for high-resolution conditional mutagenesis
M Hermann, P Stillhard, H Wildner, D Seruggia, V Kapp, ...
Nucleic acids research 42 (6), 3894-3907, 2014
Magnetic tweezers measurements of the nanomechanical properties of DNA in the presence of drugs
D Salerno, D Brogioli, V Cassina, D Turchi, GL Beretta, D Seruggia, ...
Nucleic acids research 38 (20), 7089-7099, 2010
BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells
DN Debruyne, R Dries, S Sengupta, D Seruggia, Y Gao, B Sharma, ...
Nature 572 (7771), 676-680, 2019
Rational targeting of a NuRD subcomplex guided by comprehensive in situ mutagenesis
F Sher, M Hossain, D Seruggia, VAC Schoonenberg, Q Yao, P Cifani, ...
Nature genetics 51 (7), 1149-1159, 2019
The PEG13-DMR and brain-specific enhancers dictate imprinted expression within the 8q24 intellectual disability risk locus
C Camprubi, CV Garcia, A Guillaumet-Adkins, A Sparago, D Seruggia, ...
Epigenetics & chromatin 7 (1), 1-13, 2014
TAF5L and TAF6L maintain self-renewal of embryonic stem cells via the MYC regulatory network
D Seruggia, M Oti, P Tripathi, MC Canver, L LeBlanc, DC Di Giammartino, ...
Molecular cell 74 (6), 1148-1163. e7, 2019
Yap1 safeguards mouse embryonic stem cells from excessive apoptosis during differentiation
L LeBlanc, BK Lee, CY Andy, M Kim, AV Kambhampati, SM Dupont, ...
Elife 7, e40167, 2018
Controlled removal of a nonviral episomal vector from transfected cells
S Rupprecht, C Hagedorn, D Seruggia, T Magnusson, E Wagner, M Ogris, ...
Gene 466 (1-2), 36-42, 2010
JNK-mediated disruption of bile acid homeostasis promotes intrahepatic cholangiocarcinoma
E Manieri, C Folgueira, ME Rodríguez, L Leiva-Vega, L Esteban-Lafuente, ...
Proceedings of the National Academy of Sciences 117 (28), 16492-16499, 2020
Enhancer dependence of cell-type–specific gene expression increases with developmental age
W Cai, J Huang, Q Zhu, BE Li, D Seruggia, P Zhou, M Nguyen, Y Fujiwara, ...
Proceedings of the National Academy of Sciences 117 (35), 21450-21458, 2020
Concepts and tools for gene editing
S Josa, D Seruggia, A Fernández, L Montoliu
Reproduction, Fertility and Development 29 (1), 1-7, 2017
CRISPR/Cas9 approaches to investigate the noncoding genome
D Seruggia, L Montoliu
Genome editing, 31-43, 2016
CMV-based episomal vector is progressively lost in vivo in multi-gene transgenic pigs produced by SMGT
R Giovannoni, A Vargiolu, S Manzini, M De Cecco, D Seruggia, ...
9th Transgenic Technology Meeting (TT2010), 2010
The structure and function of the mouse tyrosinase locus
D Seruggia, S Josa, A Fernández, L Montoliu
Pigment Cell & Melanoma Research 34 (2), 212-221, 2021
The system can't perform the operation now. Try again later.
Articles 1–20